AmBisome® as antifungal primary prophylaxis in patients undergoing allogeneic stem cell transplantation from alternative donor: preliminary results of phase II "Prophessor" trial

被引：0
|
作者：
Ciceri, F. [1 ]
Bacigalupo, A. [2 ]
Bregni, M. [1 ]
Busca, A. [3 ]
Giardini, C. [4 ]
Scime, R. [5 ]
Visani, G. [4 ]
Balzano, R. L. [6 ]
Picaro, L. A. [6 ]
Aversa, F. [7 ]
机构：
[1] Ist Sci San Raffaele, I-20132 Milan, Italy
[2] San Martino Hosp, Genoa, Italy
[3] Le Molinette Hosp, Turin, Italy
[4] San Salvatore Hosp, Pesaro, Italy
[5] Cervello Hosp, Palermo, Italy
[6] Gilead Sci Srl, Milan, Italy
[7] Univ Perugia, I-06100 Perugia, Italy
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [21] Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation
    Hashino, Satoshi
    Morita, Lena
    Takahata, Mutsumi
    Onozawa, Masahiro
    Nakagawa, Masao
    Kawamura, Takahito
    Fujisawa, Fumie
    Kahata, Kaoru
    Izumiyama, Koh
    Yonezumi, Masakatsu
    Chiba, Koji
    Kondo, Takeshi
    Asaka, Masahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 87 (01) : 91 - 97
  • [22] Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation
    Satoshi Hashino
    Lena Morita
    Mutsumi Takahata
    Masahiro Onozawa
    Masao Nakagawa
    Takahito Kawamura
    Fumie Fujisawa
    Kaoru Kahata
    Koh Izumiyama
    Masakatsu Yonezumi
    Koji Chiba
    Takeshi Kondo
    Masahiro Asaka
    International Journal of Hematology, 2008, 87 : 91 - 97
  • [23] DECREASE OF INVASIVE FUNGAL DISEASE IN OUR CENTER WITH THE USE OF VORICONAZOLE AS ANTIFUNGAL PROPHYLAXIS IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
    Llamas Poyato, M. J.
    Chic Acevedo, C.
    Garcia, E.
    Buenasmananas, D.
    Serrano, J.
    Molina, J. R.
    Martin, C.
    Rojas, R.
    HAEMATOLOGICA, 2014, 99 : 168 - 168
  • [24] Letermovir prophylaxis for cytomegalovirus in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
    Wang, Qingwei
    Liu, Minyuan
    Zhang, Senlin
    Gao, Li
    Chu, Xinran
    Li, Bohan
    Cheng, Shengqin
    Tian, Yuanyuan
    Zhang, Yongping
    Hu, Yixin
    Li, Jie
    Lu, Jun
    Xiao, Peifang
    Liu, Hu
    Hu, Shaoyan
    BONE MARROW TRANSPLANTATION, 2025, : 422 - 424
  • [25] EFFICACY COMPARISON OF LEVOFLOXACIN AND RIFAXIMIN PROPHYLAXIS IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
    Akyol, Gulsah
    Patat, Yakup
    Unal, Ali
    Keklik, Muzaffer
    Kaynar, Leylagul
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 441 - 442
  • [26] Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study
    Xhaard, Alienor
    Porcher, Raphael
    Bergeron, Anne
    Alanio, Alexandre
    Touratier, Sophie
    Bretagne, Stephane
    de Margerie-Mellon, Constance
    de Fontbrune, Flore Sicre
    Itzykson, Raphael
    Coman, Tereza
    Robin, Marie
    Cabannes-Hamy, Aurelie
    Socie, Gerard
    de Latour, Regis Peffault
    ANNALS OF HEMATOLOGY, 2019, 98 (04) : 1033 - 1035
  • [27] Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study
    Aliénor Xhaard
    Raphael Porcher
    Anne Bergeron
    Alexandre Alanio
    Sophie Touratier
    Stéphane Bretagne
    Constance de Margerie-Mellon
    Flore Sicre de Fontbrune
    Raphael Itzykson
    Tereza Coman
    Marie Robin
    Aurélie Cabannes-Hamy
    Gérard Socié
    Régis Peffault de Latour
    Annals of Hematology, 2019, 98 : 1033 - 1035
  • [28] Anidulafungin primary antifungal prophylaxis in 36 high-risk haematological patients undergoing haematopoietic stem cell transplantation
    Matteazzi, F.
    Levati, G.
    Assanelli, A.
    Mastaglio, S.
    Carrabba, M.
    Guggiari, E.
    Greco, R.
    Forcina, A.
    Tassara, M.
    Lupo-Stanghellini, M.
    Vago, L.
    Gentner, B.
    Corti, C.
    Ciceri, F.
    Peccatori, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S131 - S132
  • [29] A Phase II Study of Tacrolimus and Thymoglobulin, As Graft-Versus-Host-Disease Prophylaxis in Patients Undergoing Related Donor Allogeneic Hematopoietic Cell Transplantation
    Modi, Dipenkumar
    Chen, Wei
    Hyejeong, Jang
    Deol, Abhinav
    Ayash, Lois
    Asif, Alavi
    Bhutani, Divaya
    Mellert, Kendra
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    BLOOD, 2016, 128 (22)
  • [30] Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation
    Schonfeld, Warren
    Cheng, J. Wang
    Tong, Kuo B.
    Seifeldin, Raafat
    CLINICAL THERAPEUTICS, 2008, 30 (05) : 964 - 973
12345